Korean and Japanese scientists discuss US license procedures for antibody products and therapeutics

Published: 2010-11-08 06:58:00

Updated: 2010-11-08 06:58:00

At a recent workshop organized by the Korea Drug Research Association on November 4, a variety of the US license procedures for new antibodies were discussed between Korean and Japanese scientists.

“The manufacture of new antibodies consists of two processes - culture and purification. The sin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK